nxf5epkr | Knowledge4COVID-19

Property	Value
?:abstract	We investigated the dynamics of seroconversion in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. During March 29–May 22, 2020, we collected serum samples and associated clinical data from 177 persons in London, UK, who had SARS-CoV-2 infection. We measured IgG against SARS-CoV-2 and compared antibody levels with patient outcomes, demographic information, and laboratory characteristics. We found that 2.0%–8.5% of persons did not seroconvert 3–6 weeks after infection. Persons who seroconverted were older, were more likely to have concurrent conditions, and had higher levels of inflammatory markers. Non-White persons had higher antibody concentrations than those who identified as White; these concentrations did not decline during follow-up. Serologic assay results correlated with disease outcome, race, and other risk factors for severe SARS-CoV-2 infection. Serologic assays can be used in surveillance to clarify the duration and protective nature of humoral responses to SARS-CoV-2 infection.
is ?:annotates of	<https://research.tib.eu/covid-19/entity/nxf5epkr_hasAnnotation_C1175743> <https://research.tib.eu/covid-19/entity/nxf5epkr_hasAnnotation_C5203676>
?:creator	<https://research.tib.eu/covid-19/entity/Staines%2C_Henry_M.%3B_Kirwan%2C_Daniela_E.%3B_Clark%2C_David_J.%3B_Adams%2C_Emily_R.%3B_Augustin%2C_Yolanda%3B_Byrne%2C_Rachel_L.%3B_Cocozza%2C_Michael%3B_Cubas-Atienzar%2C_Ana_I.%3B_Cuevas%2C_Luis_E.%3B_Cusinato%2C_Martina%3B_Davies%2C_Benedict_M.O.%3B_Davis%2C_Mark%3B_Davis%2C_Paul%3B_Duvoix%2C_Annelyse%3B_Eckersley%2C_Nicholas_M.%3B_Forton%2C_Daniel%3B_Fraser%2C_Alice_J.%3B_Garrod%2C_Gala%3B_Hadcocks%2C_Linda%3B_Hu%2C_Qinxue%3B_Johnson%2C_Michael%3B_Kay%2C_Grant_A.%3B_Klekotko%2C_Kesja%3B_Lewis%2C_Zawditu%3B_Macallan%2C_Derek_C.%3B_Mensah-Kane%2C_Josephine%3B_Menzies%2C_Stefanie%3B_Monahan%2C_Irene%3B_Moore%2C_Catherine_M.%3B_Nebe-von-Caron%2C_Gerhard%3B_Owen%2C_Sophie_I.%3B_Sainter%2C_Chris%3B_Sall%2C_Amadou_A.%3B_Schouten%2C_James%3B_Williams%2C_Christopher_T.%3B_Wilkins%2C_John%3B_Woolston%2C_Kevin%3B_Fitchett%2C_Joseph_R.A.%3B_Krishna%2C_Sanjeev%3B_Planche%2C_Tim>
?:doi	<https://research.tib.eu/covid-19/entity/10.3201/eid2701.203074>
?:doi	10.3201/eid2701.203074
?:journal	Emerg_Infect_Dis
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/0e3f505abf5b9946bb7f385e58d56e78d1666eb0.json
?:pmc_json_files	document_parses/pmc_json/PMC7774532.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7774532>
?:pmid	<https://research.tib.eu/covid-19/entity/33256890.0>
?:pmid	33256890.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/0e3f505abf5b9946bb7f385e58d56e78d1666eb0>
?:source	Medline; PMC
?:title	IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2021-01-15

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/nxf5epkr>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/nxf5epkr>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all